POPSUGAR: Should you get the COVID-19 vaccine if you've already had the virus? Experts weigh in
UC expert says the vaccine may trigger a more vigorous immune response
As COVID-19 cases continue to soar, millions of Americans are anxiously awaiting a COVID-19 vaccine that will allow us to return to some level of normalcy. With one vaccine receiving FDA approval for emergency use and others on the horizon, some are wondering whether or not you should get the vaccine if you've already had COVID-19.
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine. Photo/Colleen Kelley/UC Creative + Brand
POPSUGAR put that question to some infectious disease experts, including Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.
Fichtenbaum said that based on current knowledge, there's no harm in receiving the vaccine.
"It may stimulate a more vigorous immune response and sometimes that can make people feel bad for a couple of days," Fichtenbaum said. "We don't know if natural immunity after infection protects people, [but] we do know that a couple of vaccines do protect against disease."
Lead photo/Getty Images
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Pocket-sized population threat
May 18, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
UC finds integrating substance use disorder treatment into clinic-based internal medicine expands access to care
May 18, 2026
A University of Cincinnati primary care teaching clinic integrates substance use disorder treatment into resident training, expanding access to addiction care and boosting physician confidence.
Colorado silica dust trial could change the way industry does business
May 17, 2026
Betsy Malloy, Andrew Katsanis Professor of Law, at the University of Cincinnati, spoke with Bloomberg Law about how a Colorado trial could change the way the stone fabrication industry does business.